Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

Bull Exp Biol Med. 2016 May;161(1):108-11. doi: 10.1007/s10517-016-3357-7. Epub 2016 Jun 6.

Abstract

Peripheral blood plasma profiles of circulating microRNA expression were analyzed in patients with prostatic cancer and benign hyperplasia. In prostatic cancer, significant increase in hsa-miR-619-5p and hsa-miR-1184 microRNA expression and significant decrease in hsalet-7b-5p and hsa-let-7c-5p microRNA expression were observed. The role of the relationship between the microRNA expression and the activities and functions of host genes with introns encoding these microRNA is discussed.

Keywords: benign prostatic hyperplasia; blood plasma; microRNA; microchip analysis; prostatic cancer.

Publication types

  • Comparative Study

MeSH terms

  • Biomarkers, Tumor / blood*
  • Diagnosis, Differential
  • Humans
  • Male
  • MicroRNAs / blood*
  • Prostatic Hyperplasia / blood*
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis

Substances

  • Biomarkers, Tumor
  • MIRN-619 microRNA, human
  • MIRN1184 microRNA, human
  • MicroRNAs